A review of blinding in randomized controlled trials found results inconsistent and questionable

被引:68
作者
Boutron, I [1 ]
Estellat, C
Ravaud, P
机构
[1] INSERM, U738, F-75018 Paris, France
[2] Grp Hosp Bichat Claude Bernard, Dept Epidemiol Biostat & Rech Clin, F-75018 Paris, France
[3] Univ Paris 07, Fac Xavier Bichat, F-75018 Paris, France
关键词
double-blind method; randomized controlled trials; methods; standards; research design; single-blind method;
D O I
10.1016/j.jclinepi.2005.04.006
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background and Objective: To determine methods to assess the success of blinding in randomized controlled trials (RCTs). Methods: We searched MEDLINE, the Cochrane Controlled Trials Register, and the Cochrane Method Register and performed a manual search to target studies that attempt to assess blinding and describe the methods used in those studies. Results: A total of 90 reports were selected. Reports assessed the success of blinding participants (n = 58), care providers (n = 36), and outcome assessors (n = 15). Of the 58 reports assessing the success of blinding participants, 54 (93%) reported asking participants to guess their treatment assignment. There was no consistency in timing of assessment (e.g., once at the end of the trial, 57%, or several times during the trial, 26%) or modalities of answering (e.g., "do not know" answers, 43%, or participants forced to guess, 31%). A statistical analysis was performed in 57% of reports. The statistical analysis mainly compared the proportion of correct guesses to those produced by chance (32%) or checked for a relation between participants' guesses and treatment assignment (23%). Conclusions: Methods of assessing the success of blinding, analysis and reporting the results were inconsistent and questionable. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1220 / 1226
页数:7
相关论文
共 32 条
[1]   Turning a blind eye - Testing the success of blinding and the CONSORT statement [J].
Altman, DG ;
Schulz, KF ;
Moher, D .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7448) :1135-1135
[2]   The revised CONSORT statement for reporting randomized trials: Explanation and elaboration [J].
Altman, DG ;
Schulz, KF ;
Moher, D ;
Egger, M ;
Davidoff, F ;
Elbourne, D ;
Gotzsche, PC ;
Lang, T .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :663-694
[3]   Assessment of blinding in clinical trials [J].
Bang, HJ ;
Ni, LY ;
Davis, CE .
CONTROLLED CLINICAL TRIALS, 2004, 25 (02) :143-156
[4]  
BLUMENTHAL DS, 1974, ARCH GEN PSYCHIAT, V31, P214
[5]   Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials [J].
Boutron, I ;
Tubach, F ;
Giraudeau, B ;
Ravaud, P .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2004, 57 (06) :543-550
[6]   Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis [J].
Boutron, I ;
Tubach, F ;
Giraudeau, B ;
Ravaud, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (08) :1062-1070
[7]  
BRENNAN AS, 2004, BMJ 0323
[8]  
CHATURVEDI SK, 2004, BLIND EVALUATION BLI
[9]  
DEONANDAN RS, 2004, BMJ MAR
[10]   Lessons learned from attempts to establish the blind in placebo-controlled trials of zinc for the common cold [J].
Desbiens, NA .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (04) :302-303